Orchard Venture Partners is a healthcare venture capital firm that was founded in 2004. The firm invests in tangible scientific assets, moves them through clear clinical milestones, and sells to innovation-hungry large medical companies.

The confluence of technology and biology has created world-changing medical opportunities. At the same time market conditions have created compelling investment opportunities.

Supply: Early-stage valuations have rarely been as attractive.
Demand: Demand for mid- to late-stage products is reaching new highs. Major medical companies are in dire need of new products as the last generation’s blockbusters reach the end of their patent lives.

Orchard systematically moves assets from early-stage to mid- or late-stage; focusing on tangible scientific assets, clear value-adding milestones, business execution, and capital efficiency.

With an extensive network that spans numerous labs and universities, a leading board of advisors, proven experience and demonstrated successes Orchard offers deep exposure to global innovation and growth.